From April 17-22, 2026, the American Association for Cancer Research (AACR) held their annual meeting in San Diego, CA. The AACR Annual Meeting brings together clinicians, researchers, and health-care professionals […]
Researchers Identify Tumor-Suppressing Mechanism in Healthy Pancreas
The American Association for Cancer Research (AACR) held their annual meeting in San Diego, CA from April 17-22, 2026. The AACR Annual Meeting gathers cancer researchers from around the world […]
Unprecedented Results from Revolution Medicines for Patients with Metastatic Pancreatic Cancer
Revolution Medicines announced exciting results on three clinical trials evaluating daraxonrasib, their oral RAS inhibitor, that have the potential to transform treatment options for patients with metastatic pancreatic ductal adenocarcinoma […]
Promising results combining immunotherapy and chemotherapy before surgery in pancreatic cancer
A recent study published in Nature Communications, sponsored by the UCLA Health Jonsson Comprehensive Cancer Center, showed that adding immunotherapy to standard chemotherapy, before surgery, may benefit a subset of […]
pNET Treatments and Emerging Research
As an overview of Pancreatic Neuroendocrine Tumors, we look at the current standard treatment for pNETs and what emerging therapies are on the horizon. Also discussed is the translational research […]
Hirshberg Foundation Launches PNET Pathway Grant Program to Accelerate Research
The Hirshberg Foundation for Pancreatic Cancer Research is proud to announce the launch of the PNET Pathway Grant Program, a new research initiative focused on accelerating discoveries in pancreatic neuroendocrine […]